Hematologist
Hospital Clínic de Barcelona, Spain
Luis Gerardo Rodríguez Lobato is a physician-scientist specialized in hematology. He was born in 1985. He studied Medicine at the National Autonomous University of Mexico. After a fellowship in Internal Medicine in México City, he moved to Barcelona where he completed his training in Hematology at Hospital Clínic of Barcelona. He received the distinction of being the best fellow in his promotion. He obtained a Master’s in hematopoietic stem cell transplantation from the University of Valencia and a Ph.D. in Monoclonal Gammopathies from the University of Barcelona under the supervision of Dr. Carlos Fernández de Larrea and Dr. Joan Bladé. His doctoral thesis was on the mechanism of progression in light chain amyloidosis (2018; “Cum Laude mention”). After this, he obtained the distinction to join the BITRECS program (“Biomedicine international training research program for excellent clinician-scientists”), under funds from the Marie Curie program, to carry out his post-doctoral studies in immunotherapy in multiple myeloma (MM), under the mentoring of Dr. Fernandez de Larrea. He carried out one year of his post-doctoral studies in CAR T-cells in MM in one of the most reputable CAR T-cell therapy institutions in Europe at the University of Würzburg in Germany with Dr. Hudecek and Dr. Einsele, analyzing different strategies to up-regulate the expression of BCMA to increase CAR T-cell efficacy. Subsequently, he continued his postdoctoral fellowship at FRCB-IDIBAPS developing bispecific CARTs in MM. He is currently a medical staff of the Department of Hematology at Hospital Clínic of Barcelona, an accredited researcher in the “Myeloma, Amyloidosis, Macroglobulinemia, and other gammopathies” Group at FRCB-IDIBAPS, member of the “Amyloidosis and Myeloma”, and “Advanced Immunotherapy” Units at Hospital Clínic of Barcelona, and teaching assistant at the University of Barcelona. Furthermore, Dr. Rodríguez-Lobato also has skills and experience in clinical and translational research and in advanced biostatistics.